Is Adagene (ADAG) Outperforming Other Medical Stocks This Year?

Group 1 - Adagene Inc. Sponsored ADR (ADAG) is part of the Medical sector, which consists of 974 individual stocks and holds a Zacks Sector Rank of 7 [2] - The Zacks Rank system, which focuses on earnings estimates and revisions, currently assigns Adagene a Zacks Rank of 2 (Buy) [3] - Over the past quarter, the Zacks Consensus Estimate for ADAG's full-year earnings has increased by 10.1%, indicating improved analyst sentiment [4] Group 2 - Year-to-date, Adagene has gained approximately 4%, outperforming the Medical sector average loss of about 2.4% [4] - Adagene belongs to the Medical - Biomedical and Genetics industry, which includes 486 stocks and currently ranks 102 in the Zacks Industry Rank [6] - Stocks in the Medical - Biomedical and Genetics industry have seen an average gain of about 3.8% this year, indicating that Adagene is performing better than its industry peers [6] Group 3 - CorMedix (CRMD), another stock in the Medical sector, has achieved a year-to-date return of 66.9% and has a Zacks Rank of 1 (Strong Buy) [5] - The consensus EPS estimate for CorMedix has increased by 30.8% over the past three months, reflecting strong analyst confidence [5] - Both Adagene and CorMedix are highlighted as stocks to watch in the Medical sector due to their solid performance [7]